Bionano Genomics, Inc.
BNGO
$3.65
-$0.05-1.35%
NASDAQ
| 03/31/2025 | 12/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -20.90% | 34.41% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -20.90% | 34.41% | |||
| Cost of Revenue | -25.85% | -67.31% | |||
| Gross Profit | -14.02% | 140.46% | |||
| SG&A Expenses | 955.26% | -90.96% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 64.41% | -68.38% | |||
| Operating Income | -827.16% | 95.96% | |||
| Income Before Tax | 84.62% | 54.49% | |||
| Income Tax Expenses | 600.00% | -95.83% | |||
| Earnings from Continuing Operations | 84.59% | 54.52% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 84.59% | 54.52% | |||
| EBIT | -827.16% | 95.96% | |||
| EBITDA | -548.95% | 107.86% | |||
| EPS Basic | 90.58% | 60.47% | |||
| Normalized Basic EPS | 66.93% | 78.34% | |||
| EPS Diluted | 90.58% | 60.47% | |||
| Normalized Diluted EPS | 66.93% | 78.34% | |||
| Average Basic Shares Outstanding | 63.61% | 15.05% | |||
| Average Diluted Shares Outstanding | 63.61% | 15.05% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||